553O Prognostic value of KRAS and BRAF mutations in ...

We studied the prognostic impact of individual KRAS exon 2 and BRAFV600E mutations in pts with surgically resected stage III CC who participated in 7 clinical ...

553O. Prognostic value of KRAS and BRAF mutations in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: An ACCENT/IDEA pooled analysis of ...

Prognostic value of KRAS and BRAF mutations in curatively ... - NCBI

BRAF mutations were poor prognostic factors for DFS (HR = 2.20; 95%CI: 1.19-4.06) and OS (HR = 2.30; 95%CI: 1.15-4.71). Neither the BRAF by MSI interaction test ...

553O Prognostic value of KRAS and BRAF mutations in ...

Semantic Scholar extracted view of "553O Prognostic value of KRAS and BRAF mutations in microsatellite stable (MSS) and unstable (MSI) stage III colon ...

553O Prognostic value of KRAS and BRAF mutations in ...

553O Prognostic value of KRAS and BRAF mutations in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: An ACCENT/IDEA pooled analysis of 7 ...

An ACCENT/IDEA pooled analysis of 7 trials - Cancer Trial Results

553O - Prognostic value of KRAS and BRAF mutations in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: An ACCENT/IDEA pooled analysis ...

Prognostic Value of BRAF and KRAS Mutations in MSI ... - PubMed

In a pooled analysis of resected stage III colon cancer patients receiving adjuvant FOLFOX, BRAF or KRAS mutations are independently ...

The prognostic significance of KRAS and BRAF mutation status in ...

BRAF and KRAS mutations are well-established biomarkers in anti-EGFR therapy. However, the prognostic significance of these mutations is ...

Different prognostic values of KRAS exon 2 sub-mutations and ...

The prognostic value of KRAS exon 2 sub-mutations were also analyzed. Results: Among 8,460 pts of which 11.4% were MSI-H, BRAFV600E, KRAS exon 2 ...

ESMO 2023: Impact of concomitant medication on recurrence ...

553O - Prognostic value of KRAS and BRAF mutations in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: An ACCENT/IDEA pooled analysis ...

T Yoshino - Dept Gastroenterol & Gastrointestinal Oncol, Natl Canc ...

553O Prognostic Value of KRAS and BRAF Mutations in Microsatellite Stable (MSS) and Unstable (MSI) Stage III Colon Cancer: an ACCENT/IDEA Pooled Analysis of ...

Influence of anatomical subsite on the incidence of microsatellite ...

https://doi.org/10.7717/peerj.5530 · Full text. 2018, PeerJ, p. e5530. Scopus. WoS. Crossref citations: 1 · Prognostic value of KRAS mutations in stage III ...

eCase - ESMO 2023 Highlights | CCO

Abstract 553O. Taieb J, Sinicrope F, Pederson L, et al. Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite ...

Clinical Signatures of Mucinous and Poorly Differentiated ... - LWW

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer. Br J Cancer. 2011;104:856–862. Cited Here... 33. Saridaki Z ...

Articles | Medical Oncology - SpringerLink

KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review ... prognostic value and ...

نتائج البحث - "Ogino S" :: Library Catalog - صفحة البحث الرئيسية

553O Prognostic value of KRAS and BRAF mutations in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: An ACCENT/IDEA pooled analysis of ...

Thomas J. George - AIM Center for Investment Management, C. T. ...

553O Prognostic Value of KRAS and BRAF Mutations in Microsatellite Stable (MSS) and Unstable (MSI) Stage III Colon Cancer: an ACCENT/IDEA Pooled Analysis of ...

Context-dependent interpretation of the prognostic value of BRAF ...

The mutation status of the BRAF and KRAS genes has been proposed as prognostic biomarker in colorectal cancer. Of them, only the BRAF V600E ...

Levi Pederson | Acemap

BRAF Mutations. Cite Source · 10.1016/j.annonc.2023.08.006. Citations (13). 553O Prognostic value of KRAS and BRAF mutations in microsatellite stable (MSS) and ...